Cyclacel Pharmaceuticals Stock (NASDAQ: CYCC) stock price, news, charts, stock research, profile.
You can purchase shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC) through any online brokerage.
Other companies in Cyclacel Pharmaceuticals’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO), Quoin Pharmaceuticals (NASDAQ:QNRX) and Onconetix (NASDAQ:ONCO).
Cyclacel Pharmaceuticals has a consensus price target of $9.50.
The stock price for Cyclacel Pharmaceuticals (NASDAQ: CYCC) is $1.03 last updated September 24, 2024 at 6:15 PM EDT.
There are no upcoming dividends for Cyclacel Pharmaceuticals.
Cyclacel Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Cyclacel Pharmaceuticals.
Cyclacel Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.